Detalles de la búsqueda
1.
CXCR4 PET/MRI for follow-up of gastric mucosa-associated lymphoid tissue lymphoma after first-line Helicobacter pylori eradication.
Blood
; 139(2): 240-244, 2022 01 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34525196
2.
Risk as a pattern over time: Delineation of time-dependent risk factors in biological, psychological, and social variables in cancer patients.
Cancer
; 129(21): 3466-3475, 2023 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37470252
3.
Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).
CA Cancer J Clin
; 66(2): 153-71, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26773441
4.
A phase II study of the PI3K inhibitor copanlisib in combination with the anti-CD20 monoclonal antibody rituximab for patients with marginal zone lymphoma: treatment rationale and protocol design of the COUP-1 trial.
BMC Cancer
; 21(1): 749, 2021 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34187401
5.
Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatment.
Haematologica
; 105(11): 2592-2597, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33131248
6.
PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations.
Eur J Nucl Med Mol Imaging
; 47(1): 51-60, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31410538
7.
Immunomodulatory treatment for mucosa-associated lymphoid tissue lymphoma (MALT lymphoma).
Hematol Oncol
; 38(4): 417-424, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32469432
8.
Transformed mucosa-associated lymphoid tissue lymphomas: A single institution retrospective study including polymerase chain reaction-based clonality analysis.
Br J Haematol
; 186(3): 448-459, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31124124
9.
Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin Analogs.
Oncologist
; 24(2): 255-258, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30171068
10.
A MALT lymphoma prognostic index.
Blood
; 130(12): 1409-1417, 2017 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28720586
11.
Prolonged follow-up on lenalidomide-based treatment for mucosa-associated lymphoid tissue lymphoma (MALT lymphoma)-Real-world data from the Medical University of Vienna.
Hematol Oncol
; 37(4): 345-351, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31283840
12.
Treatment of mucosa associated lymphoid tissue lymphoma with a long-term once-weekly regimen of oral azithromycin: Results from the phase II MALT-A trial.
Hematol Oncol
; 37(1): 22-26, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30153341
13.
Gastrointestinal Involvement in Patients with Mantle Cell Lymphoma: A Single Center Experience of Eighty-Five Patients.
Dig Dis
; 37(3): 194-200, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30677768
14.
IELSG40/CLEO phase II trial of clarithromycin and lenalidomide in relapsed/refractory extranodal marginal zone lymphoma.
Haematologica
; 108(6): 1671-1675, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36546422
15.
Ultra-early response assessment in lymphoma treatment: [18F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment.
Eur J Nucl Med Mol Imaging
; 45(6): 931-940, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29480328
16.
A pilot phase II study of ofatumumab monotherapy for extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphoma.
Hematol Oncol
; 36(1): 49-55, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28695630
17.
Immunohistochemical expression of cereblon and MUM1 as potential predictive markers of response to lenalidomide in extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma).
Hematol Oncol
; 36(1): 62-67, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28833354
18.
Long-term safety and activity of cladribine in patients with extranodal B-cell marginal zone lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphoma.
Hematol Oncol
; 35(2): 177-186, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26580149
19.
Delayed Efficacy After Treatment With Lenalidomide or Thalidomide in Patients With Mucosa-Associated Lymphoid Tissue Lymphoma.
Oncologist
; 21(1): 72-5, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26621040
20.
Gender Aspects in Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue: Does Sex Matter?
Oncology
; 91(5): 243-250, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27548082